Rep. Hank Johnson discussed the impact of Georgia’s biosciences sector, and CPAC supports FTC action against PBMs. We have details, plus more news on bird flu, USDA biofuel grants, and more. Don’t ...

Eric Marandett, co-chair of Choate’s Intellectual Property Litigation Practice Group, represents biotech, pharmaceutical, and technology companies in high stakes patent litigation and other ...

October is the scariest time of year. Young goblins walk the streets demanding treats, local haunted houses are packed full of fright-chasing teens, and the airwaves are filled with gore-splattered ...

Dr. Greiner's practice focuses on prosecution, opposition and litigation matters concerning German and European patents. With her experience in contentious proceedings, Elisabeth assists her clients ...

Anita Spieth, co-chair of Choate’s IP Litigation Group, has more than 10 years of experience representing life sciences and technology companies in high stakes patent infringement, trade secrets, and ...

There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers. In this episode, we talk with one of those families and ...

Jeff represents clients in patent litigation and other intellectual property issues, including some of the world's preeminent life sciences, pharmaceutical, biotech and high-tech companies. He has ...

Pauline Newman was appointed by President Ronald W. Reagan in 1984. From 1969 to 1984, Judge Newman served as Director, Patent, Trademark and Licensing Department, FMC Corporation, and as house ...

A special Friday edition with new data on 340B spending and a New York Times feature highlighting Pivot Bio's outstanding work to support farmers and the planet with biotech. (437 words, 2 minutes, 11 ...

WASHINGTON, DC (October 17, 2024 ) -- More than eight in ten voters believe that it's important for the National Institutes of Health to devote additional resources to understanding health conditions ...

A busy Monday brings all the highlights from BIO's Patient and Health Advocacy Summit last week, plus what BIO's talking about at the World Food Prize event in Iowa tomorrow. (793 words, 3 minutes, 57 ...

Day 1 of the BIO Investor Forum in San Francisco brought discussions on the fundraising environment and neurodegenerative disease targets and pipelines – we have recaps, plus more news to know today. ...